Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MDAI Stock Forecast 2026-2027
$1.89
Current Price
$60.15M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MDAI Price Targets
+217.5%
To High Target of $6.00
+164.6%
To Median Target of $5.00
+58.7%
To Low Target of $3.00
MDAI Price Momentum
+9.2%
1 Week Change
+47.7%
1 Month Change
+52.4%
1 Year Change
+33.1%
Year-to-Date Change
-41.1%
From 52W High of $3.21
+67.3%
From 52W Low of $1.13
📊 TOP ANALYST CALLS
Did MDAI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Spectral Ai is one of their latest high-conviction picks.
Latest MDAI Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, MDAI has a bullish consensus with a median price target of $5.00 (ranging from $3.00 to $6.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.89, the median forecast implies a 164.6% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Carl Byrnes at Northland Capital Markets, projecting a 217.5% upside. Conversely, the most conservative target is provided by Ryan Zimmerman at BTIG, suggesting a 58.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MDAI Analyst Ratings
2
Buy
0
Hold
0
Sell
MDAI Price Target Range
Low
$3.00
Average
$5.00
High
$6.00
Current: $1.89
Latest MDAI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MDAI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 25, 2026 | BTIG | Ryan Zimmerman | Buy | Reiterates | $3.00 |
| Feb 10, 2026 | BTIG | Ryan Zimmerman | Buy | Reiterates | $3.00 |
| Nov 12, 2025 | BTIG | Ryan Zimmerman | Buy | Maintains | $3.00 |
| Apr 2, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Mar 18, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Aug 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Aug 12, 2024 | Northland Capital Markets | Carl Byrnes | Outperform | Initiates | $6.00 |
| Jul 18, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Initiates | $3.50 |
| Jan 23, 2024 | BTIG | Ryan Zimmerman | Buy | Initiates | $4.00 |
Spectral AI Inc. (MDAI) Competitors
The following stocks are similar to Spectral Ai based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MDAI
Spectral Ai
mkt cap
55.06M
Spectral AI Inc. (MDAI) Financial Data
Spectral AI Inc. has a market capitalization of $60.15M with a P/E ratio of 29.7x. The company generates $19.65M in trailing twelve-month revenue with a -38.5% profit margin.
Revenue growth is -46.3% quarter-over-quarter, while maintaining an operating margin of -54.9% and return on equity of +132.2%.
Valuation Metrics
Market Cap
$60.15M
Enterprise Value
$58.03M
P/E Ratio
29.7x
PEG Ratio
-0.3x
Price/Sales
3.2x
Growth & Margins
Revenue Growth (YoY)
-46.3%
Gross Margin
+45.2%
Operating Margin
-54.9%
Net Margin
-38.5%
EPS Growth
-46.3%
Financial Health
Cash/Price Ratio
+25.6%
Current Ratio
0.9x
Debt/Equity
-1.8x
ROE
+132.2%
ROA
-32.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Spectral AI Inc. (MDAI) Business Model
About Spectral AI Inc.
What They Do
Develops advanced imaging and AI solutions for healthcare.
Business Model
Spectral AI generates revenue by offering its proprietary imaging technology and AI applications to hospitals, clinics, and military medical services. The company focuses on enhancing medical diagnostics, particularly for burn and chronic wounds, which allows healthcare professionals to make more informed decisions through real-time assessments.
Additional Information
With a strong emphasis on innovation, Spectral AI is positioned as a key player in the med-tech sector, leveraging AI to solve complex diagnostic challenges. The company's technology not only improves clinical outcomes but also aims to increase efficiency in patient care, highlighting its potential for growth and impact in the healthcare industry.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
65
CEO
Mr. Vincent Stanley Capone Esq.
Country
United States
IPO Year
2021
Website
www.spectral-ai.comSpectral AI Inc. (MDAI) Latest News & Analysis
Latest News
Quick Summary
Spectral AI, Inc. announced David McGuire as its new Chief Financial Officer, effective May 4, 2026. The company focuses on AI in medical diagnostics for wound care.
Why It Matters
The appointment of a new CFO often signals strategic shifts, potential changes in financial management, and impacts on company performance, which can influence stock prices and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. (Nasdaq: MDAI) will showcase its DeepView® System at the American Burn Association's Annual Meeting in Orlando, April 14-17, 2026.
Why It Matters
Spectral AI's participation in a major medical conference highlights its innovation in wound care, potentially attracting investment interest and partnerships, signaling growth opportunities.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. (MDAI) held its Q4 2025 earnings call, discussing financial performance and future outlook. Detailed insights can be found in the full transcript.
Why It Matters
The Q4 2025 earnings call for Spectral AI, Inc. provides insights into the company's financial performance and future outlook, influencing stock valuations and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. reported FY 2025 R&D revenue of $19.7M and Q4 revenue of $3.8M. Cash increased to $15.4M as of Dec 31, 2025. The company submitted a De Novo 510(k) application for its DeepView System.
Why It Matters
Spectral AI's revenue and cash position indicate financial stability. The FDA application for the DeepView System could drive future growth and increase market confidence in the company's potential.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI Inc (NASDAQ:MDAI) stock rose after securing $31.7 million from BARDA to advance its DeepView burn wound imaging platform.
Why It Matters
Spectral AI's $31.7 million funding from BARDA boosts its burn wound imaging platform, enhancing growth prospects and investor confidence in future revenues.
Source: Benzinga
Market Sentiment:
Positive
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System
29 days ago
Quick Summary
Spectral AI, Inc. has secured $31.7 million in funding from BARDA to enhance its DeepView® System for burn wound imaging, contributing an additional $9.7 million to the project.
Why It Matters
Spectral AI's $31.7 million funding from BARDA boosts its burn wound imaging tech, enhancing growth potential and market position in AI-driven medical diagnostics.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MDAI Stock
What is Spectral AI Inc.'s (MDAI) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Spectral AI Inc. (MDAI) has a median price target of $5.00. The highest price target is $6.00 and the lowest is $3.00.
Is MDAI stock a good investment in 2026?
According to current analyst ratings, MDAI has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.89. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MDAI stock?
Wall Street analysts predict MDAI stock could reach $5.00 in the next 12 months. This represents a 164.6% increase from the current price of $1.89. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Spectral AI Inc.'s business model?
Spectral AI generates revenue by offering its proprietary imaging technology and AI applications to hospitals, clinics, and military medical services. The company focuses on enhancing medical diagnostics, particularly for burn and chronic wounds, which allows healthcare professionals to make more informed decisions through real-time assessments.
What is the highest forecasted price for MDAI Spectral AI Inc.?
The highest price target for MDAI is $6.00 from Carl Byrnes at Northland Capital Markets, which represents a 217.5% increase from the current price of $1.89.
What is the lowest forecasted price for MDAI Spectral AI Inc.?
The lowest price target for MDAI is $3.00 from Ryan Zimmerman at BTIG, which represents a 58.7% increase from the current price of $1.89.
What is the overall MDAI consensus from analysts for Spectral AI Inc.?
The overall analyst consensus for MDAI is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.00.
How accurate are MDAI stock price projections?
Stock price projections, including those for Spectral AI Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 17, 2026 8:15 AM UTC